1 November 2022 false Taxfiler 2024.4 06327563business:PrivateLimitedCompanyLtd2022-11-012023-10-31 063275632022-10-31 063275632022-11-012023-10-31 06327563business:AuditExemptWithAccountantsReport2022-11-012023-10-31 06327563business:FilletedAccounts2022-11-012023-10-31 063275632023-10-31 06327563business:Director12022-11-012023-10-31 06327563business:RegisteredOffice2022-11-012023-10-31 063275632022-10-31 06327563core:WithinOneYear2023-10-31 06327563core:WithinOneYear2022-10-31 06327563core:ShareCapitalcore:PreviouslyStatedAmount2023-10-31 06327563core:ShareCapitalcore:PreviouslyStatedAmount2022-10-31 06327563core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-10-31 06327563core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-10-31 06327563core:PreviouslyStatedAmount2023-10-31 06327563core:PreviouslyStatedAmount2022-10-31 06327563business:SmallEntities2022-11-012023-10-31 06327563countries:EnglandWales2022-11-012023-10-31 06327563business:OrdinaryShareClass12022-11-012023-10-31 06327563business:OrdinaryShareClass12021-11-012022-10-31 063275632021-11-012022-10-31 iso4217:GBP xbrli:shares xbrli:pure
Company Registration No. 06327563 (England and Wales)
Mulla Pharma Limited Filleted accounts for the year ended 31 October 2023
Mulla Pharma Limited Filleted accounts Contents
Page
- 2 -
Mulla Pharma Limited Company Information for the year ended 31 October 2023
Director
Mr N Patel
Company Number
06327563 (England and Wales)
Registered Office
73 Colchester Road Leicester LE5 2DJ
Accountants
YP Finance Hawthorne House 17A Hawthorne Drive Leicester Leicestershire LE5 6DL
- 3 -
Mulla Pharma Limited Statement of financial position as at 31 October 2023
2023 
2022 
Notes
£ 
£ 
Fixed assets
Investments
1 
1 
Current assets
Cash at bank and in hand
119,841 
98,405 
Creditors: amounts falling due within one year
(5,824)
(31,686)
Net current assets
114,017 
66,719 
Net assets
114,018 
66,720 
Capital and reserves
Called up share capital
1 
1 
Profit and loss account
114,017 
66,719 
Shareholders' funds
114,018 
66,720 
For the year ending 31 October 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 31 July 2024 and were signed on its behalf by
Mr N Patel Director Company Registration No. 06327563
- 4 -
Mulla Pharma Limited Notes to the Accounts for the year ended 31 October 2023
1
Statutory information
Mulla Pharma Limited is a private company, limited by shares, registered in England and Wales, registration number 06327563. The registered office is 73 Colchester Road, Leicester, LE5 2DJ.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
4
Investments
Other investments 
£ 
Valuation at 1 November 2022
1 
Valuation at 31 October 2023
1 
5
Creditors: amounts falling due within one year
2023 
2022 
£ 
£ 
Taxes and social security
629 
3,979 
Other creditors
4,674 
27,294 
Accruals
521 
413 
5,824 
31,686 
- 5 -
Mulla Pharma Limited Notes to the Accounts for the year ended 31 October 2023
6
Share capital
2023 
2022 
£ 
£ 
Allotted, called up and fully paid:
1 Ordinary shares of £1 each
1 
1 
7
Average number of employees
During the year the average number of employees was 2 (2022: 2).
- 6 -